Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Follow-Up Loss in Patients with IBD
J Gastroenterol Hepatol; ePub 2018 Apr 17; Woo, et al
Among patients with inflammatory bowel disease (IBD) in remission state, follow-up loss rate was nearly 15% in outpatient clinics, a recent study found. Medical records of 784 IBD patients visiting an IBD clinic between January 2010 and December 2015 were reviewed retrospectively. 285 newly diagnosed IBD patients who were followed up for at least 12 months were included in the analysis. Researchers found:
- For 285 IBD patients (162 ulcerative colitis [UC], 123 Crohn’s disease [CD]), the mean disease duration was 66.3 ±34.0 months.
- 42 patients (14.7%; 27 UC, 15 CD) were lost to follow-up; 36 (85.7%) revisited the clinic.
- Travel time to clinic and C-reactive protein levels at diagnosis were significantly associated with follow-up loss.
- Step-up treatment was needed in 15 (41.7%) patients.
Woo DH, Kim KO, Kang MK, Lee SH, Jang BI, Kim TN. Predictors and clinical outcomes of follow-up loss in patients with inflammatory bowel disease. [Published online ahead of print April 17, 2018]. J Gastroenterol Hepatol. doi:10.1111/jgh.14258.
This Week's Must Reads
Must Reads in Crohn’s Disease
Ustekinumab & Health-Related Quality of Life in CD, J Crohns Colitis; ePub 2018 May 3; Sands, et al
Increased Risk of Acute MI and HF with IBD, Clin Gastroenterol Hepatol; ePub 2018 Apr 24; Aniwan, et al
Opioid Use Disorder & IBD Hospitalizations, J Crohns Colitis; ePub 2018 May 7; Cohen-Mekelburg, et al
Clinical Course of IBD with Celiac Disease, J Crohns Colitis; ePub 2018 May 7; Tse, et al
Incidence of Intestinal Infections in IBD, Inflamm Bowel Dis; ePub 2018 May 2; Barber, et al